Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
about
Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS MalignanciesExtracellular miRNA-21 as a novel biomarker in glioma: Evidence from meta-analysis, clinical validation and experimental investigations.MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression.Altered microRNA profiles in plasma exosomes from mesial temporal lobe epilepsy with hippocampal sclerosis.Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer.Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.Advances in the molecular genetics of gliomas - implications for classification and therapy.Extracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors.Evaluation Expression of Microrna-93 and Integrin Β8 in Different Types of Glioma TumorsCell-free microRNAs in blood and other body fluids, as cancer biomarkers.Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study.MicroRNAs in extracellular vesicles: potential cancer biomarkers.The choice of endogenous controls in exosomal microRNA assessments from biofluids.Prognostic role of microRNA-21 expression in gliomas: a meta-analysis.STAT5 induces miR-21 expression in cutaneous T cell lymphoma.miRNA‑1271 inhibits cell proliferation in neuroglioma by targeting fibronectin 1.Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis.MicroRNA‑21 promotes migration and invasion of glioma cells via activation of Sox2 and β‑catenin signaling.Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients.The key role of extracellular vesicles in the metastatic process.MiR-21: A key player in glioblastoma pathogenesis.Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer.Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy.Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination.Logistic regression analysis of risk factors for postoperative recurrence of spinal tumors and analysis of prognostic factors.Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.[Tumor Cells and Micro-environment in Brain Metastases].Vesiculated Long Non-Coding RNAs: Offshore Packages Deciphering Trans-Regulation between Cells, Cancer Progression and Resistance to Therapies.Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges.
P2860
Q26774431-C4BF675E-B6A3-4499-8905-EFD4809CE5A8Q37376183-596CF45D-0A3F-429B-89A7-EA594EE21B6AQ37660590-5B5E4412-023E-4FF4-8644-EC673D3EEE90Q37706147-06048B77-C9F2-4FDD-9A1C-CCF37679C8E0Q37706539-D3FB9C77-25BF-4C61-9502-15183B3055B6Q38429701-86BAC34D-4E65-43AD-ABE5-B888869AAF9AQ38600919-D3B45871-1AFA-4C43-933B-C032E89C7BB6Q38770935-4E1AB1EC-B373-40B8-8CB7-68D554DDEF22Q38777058-EE1C91D8-1679-42F3-9CA2-A60BDD2C9486Q38777383-B77D1AD0-306D-44B8-8734-3B8A827C46EDQ38821132-6073637B-43FE-4000-AE63-CB5E9564695DQ38842894-BE630E14-D870-4664-9A71-8A4518233564Q38877405-5DC81250-E382-42D4-9274-AC6C49245517Q38887851-22739AFC-B4DC-4789-AA05-5094E151C136Q38903386-5A80542A-81C6-4C13-B310-F993B2C2637AQ38929251-772D83FF-9484-48BF-B310-0822B8077890Q39665695-4D9DADCB-4E94-4955-828A-C5197226BA21Q41059613-E6E7F91B-B34B-4E53-A57A-97500A4F2AE4Q41675007-49F5883E-5D09-4A28-AE5A-578B1770AD88Q42315668-F4B4FE23-8D25-4444-A304-4EAD3D869FC2Q42370655-F1219483-CA1E-4D2B-85AB-D032DA592A9AQ47314287-3A093085-C7A4-4880-AECD-827C8DCEB637Q48095332-76CE8D96-B32B-4AAA-B3FD-85C4AD4475E2Q48517621-811F6AB7-B620-41F7-9822-670367C1B82CQ49177347-395E5DBA-5820-4B33-A065-59FFD236D1D2Q49496705-2CF27073-86CC-40F2-B5B8-A261670E141FQ50045922-29B1EA59-C41D-4473-89F4-967A6683A4D4Q52629217-E685CC70-1C1F-4F71-9221-76FFE360CBCBQ53022125-800922CE-E29E-46B1-ADE8-186E3024C2D8Q53489250-49164FF4-81A2-423B-B1A5-107AF1251314Q55071856-859A7431-A0B9-43C5-B42D-1CCFA50E72C3
P2860
Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Exosomal levels of miRNA-21 fr ...... recurrence of glioma patients.
@ast
Exosomal levels of miRNA-21 fr ...... recurrence of glioma patients.
@en
type
label
Exosomal levels of miRNA-21 fr ...... recurrence of glioma patients.
@ast
Exosomal levels of miRNA-21 fr ...... recurrence of glioma patients.
@en
prefLabel
Exosomal levels of miRNA-21 fr ...... recurrence of glioma patients.
@ast
Exosomal levels of miRNA-21 fr ...... recurrence of glioma patients.
@en
P2093
P2860
P356
P1433
P1476
Exosomal levels of miRNA-21 fr ...... recurrence of glioma patients.
@en
P2093
Chen-Guang Zhang
Jian-Xin Chen
Pei-Yin Wang
Shu-Jun Cheng
Wen-Bin Li
Xin-Zhong Zhang
P2860
P304
26971-26981
P356
10.18632/ONCOTARGET.4699
P407
P577
2015-08-10T00:00:00Z